- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01671358
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
Comparison of Contamination Rates of Medication Storage Cabinets Between Isolation and Non-isolation Rooms With Methicillin-resistant Staphylococcus Aureus (MRSA)
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Studies show high touch areas maybe contaminated with organisms such as Methicillin-resistant Staphylococcus aureus(MRSA) and vancomycin-resistant enterococci. MRSA can live on hospital surfaces for 9-14 days. Patients in rooms that were previously MRSA isolation rooms are at higher risk for developing a hospital-acquired infection.
This study is to determine if medication cabinets located outside of MRSA isolation rooms and their contents, particularly medications and the pharmacy delivery folders are at a higher risk of having MRSA colonization on them. This study will use conventional methods to determine if MRSA colonization is present and compare results between non-isolation and isolation rooms. This will evaluate if alternate measures for the reduction of MRSA colonization are needed for the MRSA isolation rooms in regards to medication delivery and storage.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
West Virginia
-
Morgantown, West Virginia, Förenta staterna, 26506
- West Virginia University Hospitals
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Patient rooms with isolation status for MRSA
- Patient rooms without isolation status for MRSA for 14 days
Exclusion Criteria:
- Rooms without medication cabinets directly outside the room
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
---|
Isolation Rooms for MRSA
Rooms that currently have a patient in them that are in isolation status due to MRSA
|
Non-isolation rooms
Rooms that have not been occupied by a patient in isolation due to MRSA for 14 days
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Presence of MRSA colonization
Tidsram: Hospital stay, an expected average of 14 days
|
Swabbing of four areas of the medication cabinet will be performed (keypad, handle, medication folder and a medication).
A Semi-quantitative sampling technique will be used to collect the samples.
A sterile saline moistened sterile cotton tip swab will be used to swab the specified areas.
The swabs will then be used to inoculate sheep blood agar plates in 4 quadrants.
The plates will be incubated for 48 hours.
The number of quadrants with growth will be identified.
Individual colonies will be removed from the plate with an inoculation loop, then streaked onto a second sheep blood agar plate.
The second plates will be incubated for 48 hours.
The colonies will then be run through standard identification tests to determine if the colonies are MRSA or not.
A comparison will be made between non-isolation and isolation rooms.
|
Hospital stay, an expected average of 14 days
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Quantification of MRSA colonization
Tidsram: Hospital stay, an expected average of 14 days
|
Swabbing of four areas of the medication cabinet will be performed (keypad, handle, medication folder and a medication).
A Semi-quantitative sampling technique will be used to collect the samples.
A sterile saline moistened sterile cotton tip swab will be used to swab the specified areas.
The swabs will then be used to inoculate sheep blood agar plates in 4 quadrants.
The plates will be incubated for 48 hours.
The number of quadrants with growth will be identified.
A comparison between the sites of swabbing will be performed.
|
Hospital stay, an expected average of 14 days
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Presence of other bacterial colonization
Tidsram: Hospital stay, an expected average of 14 days
|
Swabbing of four areas of the medication cabinet will be performed (keypad, handle, medication folder and a medication).
A Semi-quantitative sampling technique will be used to collect the samples.
A sterile saline moistened sterile cotton tip swab will be used to swab the specified areas.
The swabs will then be used to inoculate sheep blood agar plates in 4 quadrants.
The plates will be incubated for 48 hours.
The number of quadrants with growth will be identified.
Individual colonies will be removed from the plate with an inoculation loop, then streaked onto a second sheep blood agar plate.
The second plates will be incubated for 48 hours.
The colonies will be categorized as gram negative, gram positive catalase negative, Gram positive coagulase negative Staphylococcus species or methicillin-sensitive Staphylococcus aureus.
This will serve as a baseline epidemiology of the hospital and generate other possible hypotheses.
|
Hospital stay, an expected average of 14 days
|
Correlation between MRSA and active infection or colonization of patient
Tidsram: Hospital stay, an expected average of 14 days
|
The patient from the same time frame in the rooms sampled and positive for MRSA colonization will be reviewed to determine if they had active infection or were previously colonized.
|
Hospital stay, an expected average of 14 days
|
Correlation between colonization of other positive organisms and active infection or colonization of patient
Tidsram: Hospital stay, an expected average of 14 days
|
The patient from the same time frame in the rooms sampled and positive for non-MRSA colonization will be reviewed to determine if they had active infection or were previously colonized.
|
Hospital stay, an expected average of 14 days
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Allmänna publikationer
- Bures S, Fishbain JT, Uyehara CF, Parker JM, Berg BW. Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit. Am J Infect Control. 2000 Dec;28(6):465-71. doi: 10.1067/mic.2000.107267.
- Sexton T, Clarke P, O'Neill E, Dillane T, Humphreys H. Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J Hosp Infect. 2006 Feb;62(2):187-94. doi: 10.1016/j.jhin.2005.07.017. Epub 2005 Nov 14.
- Oie S, Hosokawa I, Kamiya A. Contamination of room door handles by methicillin-sensitive/methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2002 Jun;51(2):140-3. doi: 10.1053/jhin.2002.1221.
- Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med. 2006 Oct 9;166(18):1945-51. doi: 10.1001/archinte.166.18.1945.
- Huang R, Mehta S, Weed D, Price CS. Methicillin-resistant Staphylococcus aureus survival on hospital fomites. Infect Control Hosp Epidemiol. 2006 Nov;27(11):1267-9. doi: 10.1086/507965. Epub 2006 Sep 28.
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- WVU-00010
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Meticillin-resistenta Staphylococcus Aureus
-
University Hospital TuebingenHar inte rekryterat ännu
-
Centre Hospitalier Universitaire de Saint EtienneAvslutadStaphylococcus aureusFrankrike
-
University of SheffieldRajarata University, Sri LankaOkänd
-
NovaDigm Therapeutics, Inc.Uniformed Services University of the Health Sciences; Infectious Diseases...AvslutadStaphylococcus aureusFörenta staterna
-
Ohio State UniversityAvslutadMeticillinresistenta Staphylococcus Aureus | Meticillinkänslig Staphylococcus Aureus-infektionFörenta staterna
-
Todd C. Lee MD MPH FIDSAHar inte rekryterat ännuKombination av cefazolin med ertapenem för meticillinkänslig Staphylococcus Aureus bakteriemi (CERT)Staphylococcus Aureus Bakteremi | Staphylococcus Aureus Endokardit | Staphylococcus Aureus Septikemi | Staphylococcal SepsisKanada
-
Forest LaboratoriesAvslutadStaphylococcus Aureus Bakteremi | Meticillinresistent Staphylococcus Aureus (MRSA) bakteriemiFörenta staterna
-
Northwestern UniversityAvslutadNäsbärare av Staphylococcus AureusFörenta staterna
-
Intron Biotechnology, Inc.AvslutadFriska volontärer | Antibakteriella medel | Meticillin-resistenta Staphylococcus Aureus | Meticillinkänslig Staphylococcus Aureus-infektionKorea, Republiken av
-
Rothman Institute OrthopaedicsOkändStaphylococcus aureus | Total ledplastik | Nästa generations sekvenseringFörenta staterna